Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Products and license
34
48
59
72
74
108
Services
21
31
45
66
90
127
Total net revenue
55
78
104
138
164
234
Products and license
6
7
9
9
9
11
Services
6
10
13
21
27
37
Total cost of revenue
12
16
22
30
37
48
Gross Profit
43
62
82
108
127
187
Research and development
13
18
21
28
43
53
Sales and Marketing
34
43
54
82
106
136
General and administrative
8
12
15
24
34
43
Amortization of acquired intangible assets
0
0
0
0
1
1
Total operating expenses
55
72
89
133
185
235
Loss from operations
-12
-10
-7
-25
-58
-48
Other income (expense), net
0
0
0
0
0
0
Loss before provision for income taxes
-12
-10
-7
-26
-58
-48
Provision for income taxes
1
1
1
1
1
1
Net loss
-12
-11
-8
-26
-59
-49
Loss attributable to non - controlling interest
0
1
1
1
0
0
Net loss attributable to Imperva, Inc. stockholders
-12
-10
-7
-25
-59
-49
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
96
59
77
68
168
Short-term investments
n/a
2
43
38
42
97
Restricted cash
n/a
1
1
0
0
0
Accounts receivable, net of allowances
n/a
26
36
44
47
61
Inventory
n/a
0
0
1
0
1
Deferred tax assets
n/a
0
1
0
0
0
Prepaid expenses and other current assets
n/a
1
4
4
4
8
Total current assets
n/a
126
144
164
162
335
Property and equipment, net
n/a
4
6
5
8
12
Goodwill
n/a
0
0
0
35
35
Acquired intangible assets, net
n/a
0
0
0
9
8
Severance pay fund
n/a
3
3
4
4
5
Restricted cash
n/a
1
1
1
2
2
Deferred tax assets
n/a
0
0
0
0
1
Other assets
n/a
0
1
1
1
1
Total assets
n/a
134
154
176
221
398
Liabilities and owners' equity
Accounts payable
n/a
4 3534000
4 3789000
4 3948000
5 5376000
7 6870000
Accrued compensation and benefits
n/a
7 7491000
9 9258000
13 12930000
16 15749000
20 20259000
Accrued and other current liabilities
n/a
4 4408000
4 4323000
4 3961000
6 6376000
14 14283000
Deferred revenue
n/a
22 21982000
34 33609000
40 40337000
56 56077000
79 79132000
Total current liabilities
n/a
37 37415000
51 50979000
61 61176000
84 83578000
121 120544000
Other liabilities
n/a
3 2856000
3 2638000
2 1993000
10 10408000
5 4515000
Deferred revenue
n/a
11 10943000
13 12682000
23 22715000
25 25098000
28 27525000
Accrued severance pay
n/a
3 2760000
3 3427000
4 4385000
4 4318000
5 4884000
Total liabilities
n/a
54 53974000
70 69726000
90 90269000
123 123402000
157 157468000
Commitments and contingencies (Note 11)
n/a
0 0
0 0
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 2000
0 2000
0 2000
0 2000
0 3000
Additional paid-in capital
n/a
147 147085000
158 157989000
188 187957000
256 256388000
448 448069000
Accumulated deficit
n/a
-66 -66130000
-74 -73517000
-99 -98695000
-158 -157658000
-207 -206540000
Accumulated other comprehensive loss
n/a
-1 -616000
1 861000
0 -428000
-1 -1489000
-1 -1331000
Total stockholders' equity
n/a
80 80341000
85 85335000
89 88836000
97 97243000
240 240201000
Noncontrolling Interest
n/a
-1 -773000
-1 -1104000
-3 -2614000
0 0
0 0
Total stockholders' equity
n/a
80 79568000
84 84231000
86 86222000
0 0
0 0
Total liabilities and stockholders' equity
n/a
134 133542000
154 153957000
176 176491000
221 220645000
398 397669000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Feb 26, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (41 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net loss
-12
-11
-8
-26
-59
-49
Depreciation and amortization
1
2
2
3
4
5
Stock-based compensation
1
2
6
22
37
51
Revaluation of convertible preferred stock warrant liability
0
0
0
0
0
0
Amortization of acquired intangibles
0
0
0
0
1
1
Amortization of premiums/accretion of discounts on short-term investments
0
0
0
1
0
0
Allowance for doubtful debts
0
0
0
0
0
-1
Excess tax deficiencies (benefits) from share-based compensation
0
0
0
0
0
0
Accounts receivable, net
-1
-13
-10
-9
-3
-15
Inventory
0
0
0
0
0
-1
Prepaid expenses and other assets
-1
0
-2
-1
0
-4
Accounts payable
-1
1
0
0
1
1
Accrued compensation and benefits
2
2
2
4
3
5
Accrued and other liabilities
2
-1
1
0
2
3
Severance pay (net)
0
0
0
0
0
0
Deferred revenue
8
12
13
17
18
25
Deferred tax assets
0
0
0
0
0
0
Other
0
0
0
0
0
0
Net cash provided by operating activities
-1
-7
4
10
4
24
Proceeds from sales/maturities of short-term investments
1
3
16
42
30
-90
Purchase of short-term investments
-2
-3
-58
-38
-33
34
Acquisitions, net of cash acquired
0
0
0
0
-12
0
Net purchases of property and equipment
-3
-1
-3
-3
-6
-8
Purchase of other assets
0
0
0
0
0
0
Change in restricted cash
-1
0
0
0
0
0
Net cash (used in) provided by investing activities
-5
-2
-46
2
-22
-64
Proceeds from follow-on public offering, net of offering costs
0
86
0
0
0
128
Proceeds from issuance of common stock, net of repurchases
1
1
4
8
11
24
Proceeds from issuance of restricted stock
3
1
0
0
0
0
Repayment of convertible promissory note from related party
-1
0
0
0
0
0
Borrowings on revolving credit facility
1
4
0
0
0
0
Repayments of revolving credit facility
0
-5
0
0
0
0
Shares withheld for tax withholding on vesting of restricted stock units
0
0
0
-1
-2
-11
Excess tax (deficiencies) benefits from share-based compensation
0
0
0
0
0
0
Net cash provided by financing activities
3
88
4
6
9
140
Effect of exchange rate changes on cash and cash equivalents
0
0
0
0
0
0
Net increase (decrease) in cash and cash equivalents
-2
80
-37
18
-9
100
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 2, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo